Potential lung cancer vaccine shows renewed promise
Friday, March 21, 2014 - 13:02
in Health & Medicine
The investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted immune response and reduced the number of tumors in mice with lung cancer, a study has shown. "There aren't any good options for patients with inoperable stage III lung cancer following mainline chemotherapies," said the lead author. "We are looking at tecemotide as a potential maintenance therapy to prolong survival and improve quality of life."